Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDavies, Jessica F-
dc.contributor.authorTrajceska, Ljubiana-
dc.contributor.authorWeinberg, Laurence-
dc.date2023-
dc.date.accessioned2023-02-07T05:37:48Z-
dc.date.available2023-02-07T05:37:48Z-
dc.date.issued2023-01-31-
dc.identifier.citationAnaesthesia and Intensive Care 2023; 51(2)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32062-
dc.description.abstractAnaesthetic agents have various financial and environmental impacts. Climate change is one of the biggest threats to human health, and anaesthetic gases contribute to global heating by acting as greenhouse gases. The primary aim of this study was to quantify the financial and environmental impacts of anaesthesia maintenance agents used during surgery in an Australian university teaching hospital. The volume of desflurane, sevoflurane, isoflurane and propofol purchased by a university teaching hospital between 2010 and 2020 was analysed and described in terms of financial and environmental impact. Estimated carbon emissions and financial costs of each agent per annum were calculated using the volumes purchased for each agent. A model of ideal anaesthetic agent usage was used to hypothesise the financial and environmental impact of replacing desflurane (the most environmentally damaging and expensive agent) with alternative agents. Using 2019 as an example year at our health service, replacing desflurane with low flow sevoflurane would save greenhouse gas emissions equivalent to driving over 1.4 million kilometres in an average petrol car. Removing desflurane from machines at our institution could save an estimated A$14,630 per annum through reduced machine testing alone. Our findings and calculations indicate that reducing the use of desflurane would have both financial and environmental benefits for healthcare.en_US
dc.language.isoeng-
dc.subjectPharmacologyen_US
dc.subjectanaesthesiaen_US
dc.subjectanaesthetic agentsen_US
dc.subjectenvironmental sustainabilityen_US
dc.subjectgeneral interest anaesthesiaen_US
dc.subjecthealth economicsen_US
dc.subjectperioperative anaesthesiaen_US
dc.subjectpharmacologyen_US
dc.titleThe financial and environmental impact of purchased anaesthetic agents in an Australian tertiary hospital.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAnaesthesia and Intensive Careen_US
dc.identifier.affiliationAnaesthesiaen_US
dc.identifier.affiliationPharmacyen_US
dc.identifier.doi10.1177/0310057X221129291en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-2844-8865en_US
dc.identifier.orcid0000-0001-7403-7680en_US
dc.identifier.pubmedid36722013-
dc.description.startpage310057X221129291-
local.name.researcherWeinberg, Laurence
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptAnaesthesia-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

66
checked on Nov 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.